CD73 inhibitors

Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.

Saved in:
Bibliographic Details
Main Authors Fantin, Valeria R, Kawai, Hiroyuki, Zavorotinskaya, Tatiana, Blank, Brian R, Sun, Daqing, Ye, Qiuping, Pham, Johnny, Du, Xiaohui, Moore, Jared, Wu, Kejia, Eksterowicz, John, Rew, Yosup, Zhu, Liusheng
Format Patent
LanguageEnglish
Published 07.11.2023
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
Online AccessGet full text

Cover

Abstract Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
AbstractList Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Author Sun, Daqing
Ye, Qiuping
Zavorotinskaya, Tatiana
Eksterowicz, John
Moore, Jared
Du, Xiaohui
Blank, Brian R
Zhu, Liusheng
Fantin, Valeria R
Kawai, Hiroyuki
Rew, Yosup
Pham, Johnny
Wu, Kejia
Author_xml – fullname: Fantin, Valeria R
– fullname: Kawai, Hiroyuki
– fullname: Zavorotinskaya, Tatiana
– fullname: Blank, Brian R
– fullname: Sun, Daqing
– fullname: Ye, Qiuping
– fullname: Pham, Johnny
– fullname: Du, Xiaohui
– fullname: Moore, Jared
– fullname: Wu, Kejia
– fullname: Eksterowicz, John
– fullname: Rew, Yosup
– fullname: Zhu, Liusheng
BookMark eNrjYmDJy89L5WTgd3YxN1bIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoYWBuZmphZORsbEqAEACPAgPA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11807658B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11807658B23
IEDL.DBID EVB
IngestDate Fri Sep 06 06:15:08 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11807658B23
Notes Application Number: US202217697318
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231107&DB=EPODOC&CC=US&NR=11807658B2
ParticipantIDs epo_espacenet_US11807658B2
PublicationCentury 2000
PublicationDate 20231107
PublicationDateYYYYMMDD 2023-11-07
PublicationDate_xml – month: 11
  year: 2023
  text: 20231107
  day: 07
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ORIC Pharmaceuticals, Inc
RelatedCompanies_xml – name: ORIC Pharmaceuticals, Inc
Score 3.499806
Snippet Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
Title CD73 inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231107&DB=EPODOC&locale=&CC=US&NR=11807658B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTU1Nk1LNUvTNUq1MNE1sUxN0000tEjWBaYuS3PLlFSLNCPQbmRfPzOPUBOvCNMIJoYs2F4Y8Dmh5eDDEYE5KhmY30vA5XUBYhDLBby2slg_KRMolG_vFmLrogbtHQMbK6BLVF2cbF0D_F38ndWcnW1Dg9X8gmxBJ52ZA2tbJ2BxzQpsRpuDcoNrmBNoV0oBcpXiJsjAFgA0La9EiIEpNU-YgdMZdvOaMAOHL3TCG8iE5r1iEQZ-ZxdzY4XMvIzMpEzQFTmiDIpuriHOHrpAk-Ph3ogPDUY4wliMgQXYvU-VYFBIM0kzN05MTDRNsjA1STZISzI2TjMBVfTJpkkpBkmGkgxSuM2RwicpzcAFChLwzjlzGQaWkqLSVFlgFVqSJAf2OwC1g3QJ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTU1Nk1LNUvTNUq1MNE1sUxN0000tEjWBaYuS3PLlFSLNCPQbmRfPzOPUBOvCNMIJoYs2F4Y8Dmh5eDDEYE5KhmY30vA5XUBYhDLBby2slg_KRMolG_vFmLrogbtHQMbK6BLVF2cbF0D_F38ndWcnW1Dg9X8gmxBJ52ZA2tbJ2BxzQpsYpuDcoNrmBNoV0oBcpXiJsjAFgA0La9EiIEpNU-YgdMZdvOaMAOHL3TCG8iE5r1iEQZ-ZxdzY4XMvIzMpEzQFTmiDIpuriHOHrpAk-Ph3ogPDUY4wliMgQXYvU-VYFBIM0kzN05MTDRNsjA1STZISzI2TjMBVfTJpkkpBkmGkgxSuM2Rwicpz8DpEeLrE-_j6ectzcAFCh7wLjpzGQaWkqLSVFlgdVqSJAcOBwBQs3b8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CD73+inhibitors&rft.inventor=Fantin%2C+Valeria+R&rft.inventor=Kawai%2C+Hiroyuki&rft.inventor=Zavorotinskaya%2C+Tatiana&rft.inventor=Blank%2C+Brian+R&rft.inventor=Sun%2C+Daqing&rft.inventor=Ye%2C+Qiuping&rft.inventor=Pham%2C+Johnny&rft.inventor=Du%2C+Xiaohui&rft.inventor=Moore%2C+Jared&rft.inventor=Wu%2C+Kejia&rft.inventor=Eksterowicz%2C+John&rft.inventor=Rew%2C+Yosup&rft.inventor=Zhu%2C+Liusheng&rft.date=2023-11-07&rft.externalDBID=B2&rft.externalDocID=US11807658B2